MARKET

IXHL

IXHL

Incannex Healthcare Ltd
NASDAQ
3.199
-0.001
-0.03%
Opening 13:31 08/12 EDT
OPEN
3.160
PREV CLOSE
3.200
HIGH
3.215
LOW
3.090
VOLUME
56.24K
TURNOVER
--
52 WEEK HIGH
27.69
52 WEEK LOW
2.490
MARKET CAP
38.28M
P/E (TTM)
-0.2479
1D
5D
1M
3M
1Y
5Y
1D
Incannex receives additional A$5.1M R&D tax incentive refund
TipRanks · 1d ago
Incannex Healthcare Receives Final A$5.1M R&D Tax Incentive Refund Following Approval Of Its Overseas Findings And Amendment Of Its FY25 Tax Return
Benzinga · 1d ago
Incannex Secures A$5.1M R&D Tax Incentive Refund
TipRanks · 1d ago
Weekly Report: what happened at IXHL last week (0803-0807)?
Weekly Report · 2d ago
Weekly Report: what happened at IXHL last week (0727-0731)?
Weekly Report · 08/03 10:13
Weekly Report: what happened at IXHL last week (0720-0724)?
Weekly Report · 07/27 10:17
Incannex commences screening in DReAMzz trial
TipRanks · 07/23 12:10
Incannex Healthcare Begins Participant Screening In Its DReAMzz Phase 2 Dose Confirmation Study Evaluating IHL-42X To Treat Obstructive Sleep Apnea
Benzinga · 07/23 12:04
More
About IXHL
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnoea, rheumatoid arthritis, and generalized anxiety disorder. Its lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnoea. IHL-42X has completed a Phase II clinical trial. PSX-001 is a synthetic psilocybin treatment for the treatment of generalized anxiety disorder. PSX-001 has completed a Phase II clinical trial. IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. IHL-675A is in a Phase II clinical development program.

Webull offers Incannex Healthcare Inc stock information, including NASDAQ: IXHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IXHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IXHL stock methods without spending real money on the virtual paper trading platform.